For Healthcare Professionals Only
The renaming of polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) marks a significant shift in how the condition is understood within modern clinical practice. The updated terminology reflects growing recognition that PMOS is not solely a reproductive condition, but a complex endocrine and metabolic disorder with implications for fertility, pregnancy, cardiovascular health and long-term wellbeing.
The condition long known as polycystic ovary syndrome (PCOS) has officially been renamed polyendocrine metabolic ovarian syndrome (PMOS) following a global consensus published in The Lancet in May 2026.
While it may appear to be a small shift in wording, this change reflects a significant evolution in how the condition is understood and managed in clinical practice.
Why PCOS Was Renamed to PMOS
The term “polycystic ovary syndrome” has long been considered misleading.
- Many patients do not have ovarian cysts, despite the name.
- The condition is not primarily an ovarian disorder, but a broader endocrine and metabolic condition.
- The terminology contributed to delayed diagnosis, confusion, and fragmented care.
Instead, PMOS reflects the true underlying biology, including endocrine, metabolic and reproductive dysfunction - improving clinical clarity and understanding.
PMOS Is a Multisystem Condition
PMOS affects approximately 1 in 8 women globally and is now recognised as a whole‑body condition.
It is associated with:
- Metabolic dysfunction (including insulin resistance)
- Cardiovascular risk
- Mental health impacts
- Dermatological symptoms
- Reproductive and ovulatory issues
This expanded definition highlights that PMOS extends far beyond the ovaries and requires a multidisciplinary approach to care.
What PMOS Means for Fertility and Pregnancy Care
For practitioners working in fertility and pregnancy care, this shift is particularly important.
PMOS is associated with:
- Ovulatory dysfunction
- Increased risk of gestational diabetes
- Pregnancy complications
- Long‑term cardiometabolic risk
Importantly, insulin resistance and endocrine disruption are now recognised as central drivers of the condition, influencing both fertility and long‑term outcomes.
How the PMOS Definition Changes Clinical Practice
Earlier and More Accurate Diagnosis
Moving away from a cyst‑based definition allows for more accurate and earlier identification.
A More Holistic Treatment Framework
Management now focuses on metabolic, hormonal and systemic health rather than reproductive symptoms alone.
Improved Patient Understanding
The updated terminology better reflects patient experience and supports clearer communication.
Key Takeaways on the Transition From PCOS to PMOS
The transition from PCOS to PMOS represents a significant step forward in women’s health.
It reinforces the need to:
- Think beyond ovarian findings
- Prioritise metabolic and endocrine health
- Adopt a more holistic, patient‑centred approach
References
-
Teede, H.J. et al. 2026, ‘Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process’, The Lancet. Available at: View article [thelancet.com]
-
Healthline 2026, ‘PCOS is now PMOS: Doctors say name change will improve diagnosis and care’. Available at: Read article [healthline.com]
-
The Conversation 2026, ‘From PCOS to PMOS: What the name change means for women’s health’. Available at: Read article [theconversation.com]
-
AJMC 2026, ‘PCOS renamed PMOS in landmark shift reflecting metabolic and endocrine features’. Available at: Read article [ajmc.com]
Frequently Asked Questions
-
Why was PCOS renamed PMOS?
The condition was renamed because the term polycystic ovary syndrome was considered misleading. Many patients do not have ovarian cysts, and the condition is now recognised as a broader endocrine and metabolic disorder.
-
What does PMOS stand for?
PMOS stands for polyendocrine metabolic ovarian syndrome. The updated name reflects the endocrine, metabolic and reproductive aspects of the condition.
-
Is PMOS only a reproductive condition?
No. PMOS is now recognised as a multisystem condition associated with metabolic dysfunction, cardiovascular risk, mental health impacts, dermatological symptoms and reproductive issues.
-
How does PMOS affect fertility and pregnancy?
PMOS is associated with ovulatory dysfunction, increased risk of gestational diabetes, pregnancy complications and long-term cardiometabolic risk.
-
What changes in clinical practice with the move to PMOS?
The updated terminology supports earlier diagnosis, a more holistic treatment approach and improved patient understanding of the condition.
-
Why is insulin resistance important in PMOS?
Insulin resistance is now recognised as a central driver of the condition and may influence fertility, endocrine function and long-term health outcomes.
